Tobacco-based potential Covid-19 vaccine ready for human trials
Team Udayavani, May 16, 2020, 10:09 AM IST
British American Tobacco said it was ready to test its potential Covid-19 vaccine using proteins from tobacco leaves on humans, after it generated a positive immune response in pre-clinical trials.
British American Tobacco (BAT), is the world’s second-largest manufacturer of cigarettes. It is said that the vaccine has been synthesized using proteins from tobacco leaves on humans.
In April the company said it is developing a Covid-19 vaccine from tobacco leaves and could produce 1 million to 3 million doses per week if it got the support of government agencies and the right manufacturers.
The company said once it gets approval from the U.S. Food and Drug administration (FDA) for the vaccine, it would progress to Phase 1 trials or testing on humans.
Also, it has committed funds to conduct clinical trials, which it expects to start as early as late June, and invested in additional equipment to boost capacity.
Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.
Top News
Related Articles More
From Orbit to Earth: ISRO’s Contributions to Understanding Himalayan Glacial Shifts
Modi Supports Philippines with BrahMos Missiles in China Sea Dispute
LS 2024: Yet another face-off between seasoned politicians Kota Srinivas Poojary & Jayaprakash Hegde
Wish to work for betterment of my state Odisha: UPSC 2nd rank holder Animesh Pradhan
Climate change is causing marine ‘coldwaves’ too, killing wildlife
MUST WATCH
Latest Additions
Intense heat wave in eastern states spreads to south India
Sexual harassment case against ex-WFI chief: Court to pass order on closure report on May 20
Modi is ‘Vish Guru’, never respected ‘magalsutra’: Jairam Ramesh
TCS World 10K: New starting point, meticulous arrangements in place
Congress complains to EC, alleges ‘misinformation’ by BJP about manifesto